Abstract
Purpose
To analyze a large volume of image-guided liver mass biopsies to assess for an increased incidence of major hemorrhage after aggressive liver mass sampling, and to determine if coaxial technique reduces major hemorrhage rate.
Methods
Patients who underwent image-guided liver mass biopsy over a 15-year period (December 7, 2001–September 22, 2016) were retrospectively identified. An aggressive biopsy was defined as a biopsy event in which ≥ 4 core needle passes were performed. Association of major hemorrhage after aggressive liver mass biopsy and other potential risk factors of interest were assessed using logistic regression analysis. For the subset of aggressive biopsies, Fisher’s exact test was used to compare the incidence of major hemorrhage using coaxial versus noncoaxial techniques.
Results
Aggressive biopsies constituted 11.6% of biopsy events (N =579/5011). The incidence of major hemorrhage with <4 passes was 0.4% (N =18/4432) and with ≥4 passes 1.2% (N =6/579). In univariable models, aggressive biopsy was significantly associated with major hemorrhage (OR 3.0, 95% CI 1.16–6.92, p =0.025). After adjusting for gender and platelet count, the association was not significant at the p =0.05 level (OR 2.58, 95% CI 0.927–6.24, p =0.067). The rate of major hemorrhage in the coaxial biopsy technique group was 1.4% (N =3/209) compared to 1.1% (N =4/370) in the noncoaxial biopsy technique group, which was not a significant difference (p =0.707).
Conclusions
Although aggressive image-guided liver mass biopsies had an increased incidence of major hemorrhage, the overall risk of bleeding remained low. The benefit of such biopsies will almost certainly outweigh the risk in most patients.
Similar content being viewed by others
References
Ferreira BI, Hill R, Link W (2015) Special review: caught in the crosshairs: targeted drugs and personalized medicine. Cancer J (Sudbury, Mass) 21(6):441–447. https://doi.org/10.1097/PPO.0000000000000161
Conley BA, Doroshow JH (2014) Molecular analysis for therapy choice: NCI MATCH. Semin Oncol 41(3):297–299. https://doi.org/10.1053/j.seminoncol.2014.05.002
Marshall D, Laberge JM, Firetag B, Miller T, Kerlan RK (2013) The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. J Vasc Interv Radiol 24(8):1094–1103. https://doi.org/10.1016/j.jvir.2013.04.027
Tam AL, Lim HJ, Wistuba II, et al. (2016) Image-guided biopsy in the era of personalized cancer care: proceedings from the society of interventional radiology research consensus panel. J Vasc Interv Radiol 27(1):8–19. https://doi.org/10.1016/j.jvir.2015.10.019
McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99(5):1396–1400
Kohli M, Mayo-Smith W, Zagoria R, Sandrasegaran K (2016) Image-guided intervention in the coagulopathic patient. Abdom Radiol (New York) 41(4):667–676. https://doi.org/10.1007/s00261-016-0663-5
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology 49(3):1017–1044. https://doi.org/10.1002/hep.22742
Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T (2012) Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part I. Procedural aspects, diagnostic adequacy, and accuracy. Radiology 265(3):819–831. https://doi.org/10.1148/radiol.12111562
McVay PA, Toy PT (1990) Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94(6):747–753
O’Connor SD, Taylor AJ, Williams EC, Winter TC (2009) Coagulation concepts update. AJR Am J Roentgenol 193(6):1656–1664. https://doi.org/10.2214/ajr.08.2191
Segal JB, Dzik WH (2005) Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45(9):1413–1425. https://doi.org/10.1111/j.1537-2995.2005.00546.x
Kitchin DR, Del Rio AM, Woods M, Ludeman L, Hinshaw JL (2017) Percutaneous liver biopsy and revised coagulation guidelines: a 9-year experience. Abdom Radiol (New York) . https://doi.org/10.1007/s00261-017-1319-9
Mueller M, Kratzer W, Oeztuerk S, et al. (2012) Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 12:173. https://doi.org/10.1186/1471-230x-12-173
Perrault J, McGill DB, Ott BJ, Taylor WF (1978) Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 74(1):103–106
Vijayaraghavan GR, Vedantham S, Rangan V, et al. (2015) Effect of needle gauge and lobe laterality on parenchymal liver biopsy outcome: a retrospective analysis. Abdom Imaging 40(5):1223–1229. https://doi.org/10.1007/s00261-014-0290-y
Boyum JH, Atwell TD, Schmit GD, et al. (2016) Incidence and risk factors for adverse events related to image-guided liver biopsy. Mayo Clin Proc 91(3):329–335. https://doi.org/10.1016/j.mayocp.2015.11.015
Atwell TD, Smith RL, Hesley GK, et al. (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 194(3):784–789. https://doi.org/10.2214/AJR.08.2122
Institute NC (2010) Common terminology criteria for adverse events v4.0. National Cancer Institute. https://ctep.cancer.gov/. Accessed Aug 8 2017
Ziv E, Durack JC, Solomon SB (2016) The Importance of Biopsy in the Era of Molecular Medicine. Cancer J (Sudbury, Mass) 22(6):418–422
Tacher V, Le Deley MC, Hollebecque A, et al. (2016) Factors associated with success of image-guided tumour biopsies: results from a prospective molecular triage study (MOSCATO-01). Eur J Cancer 59:79–89. https://doi.org/10.1016/j.ejca.2016.02.006
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
Funding for data management and analysis was provided by the Mayo Clinic Radiology Research Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Boyum, J.H., Atwell, T.D., Wall, D.J. et al. Incidence of major hemorrhage after aggressive image-guided liver mass biopsy in the era of individualized medicine. Abdom Radiol 44, 2067–2073 (2019). https://doi.org/10.1007/s00261-018-1637-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-018-1637-6